Embed Size (px)
Citation preview
Date: March 5, 2018 To The Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001
To National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam, In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notify the schedule of Analyst / Institutional Investor Meeting as per table set out below: Day/Date Fund/Investor/Analyst/Banker Name Mode of interaction Tuesday, 6th March, 2018 Goldman Sachs and its invitees Meeting The above schedule is indicative and is subject to changes necessitated by any unforeseen developments. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Thanking You, For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 5, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, and in continuationof the intimation of investor meeting sent earlier vide our letter dated 5th March, 2018, kindly take note ofthe updated list of invitees, prospective attendees:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionTuesday, 6th March, 2018 Goldman Sachs;
Aberdeen Standard Life Investments;Surveryor Capital;Orbimed Advisors;Ishana Capital;Premji Invest;Canopy Group
Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 7, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionThursday, 8th March, 2018 Mondrian Investment Partners and
CLSAMeeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 10, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionMonday, 12th March, 2018 Anvil Share & Stock Broking Pvt. Ltd Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 21, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionThursday, 22nd March, 2018 ASK Investment Managers Con Call
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 23, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionMonday, 26th March, 2018 Ambit Capital Pvt Ltd Con Call
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 27, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionWednesday, 28th March, 2018 IIFL Institutional Equities Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: March 29, 2018
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionFriday, 30th March, 2018 Franklin Templeton Asset Management Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
